Sébastien Coppe, PhD

Sébastien Coppe, PhD, serves as the Chief Executive Officer of One2Treat, which focuses on developing advanced software for holistic evaluation of treatment effects in clinical trials. Before this role, Sébastien was the Life Sciences Vice President at N-SIDE, responsible for the management, strategy, and operations of Life Sciences activities, as well as leading a group of consultants to innovate within the Pharma R&D space. With a strong educational background including a PhD in Neuroscience and a Master of Engineering in Applied Mathematics from Université catholique de Louvain, Sébastien has extensive experience in optimizing clinical development processes for various pharmaceutical companies, significantly reducing budgets and timelines in clinical trials.